Merck & Co., Inc.'s Schering-Plough Corporation Wins OK on $165 Million Clarinex Pact

Bookmark and Share

Reuters -- A federal judge has approved a $165 million settlement by Schering-Plough Corp, a drugmaker now owned by Merck & Co (MRK.N), to resolve investor class-action lawsuits over alleged fraudulent statements regarding the allergy medicine Clarinex.

Back to news